Ultra Low Iodine Loaded Spectral CT Angiography (CTA)

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

October 16, 2020

Study Completion Date

October 16, 2020

Conditions
Peripheral Arterial DiseaseRenal Insufficiency
Interventions
DIAGNOSTIC_TEST

Half iodine Spectral CT

Patients receive half dosage of iodine contrast agent, and Spectral CT acquisition with Virtual Monoenergetic Images at 40 and 50 keV.

DIAGNOSTIC_TEST

Standard iodine conventional CT

Patients receive standard dosage of iodine contrast agent, and conventional 120 kv Polychromatic CT acquisition.

Trial Locations (1)

1478

Akershus University Hospital, Lørenskog

All Listed Sponsors
collaborator

Oslo Metropolitan University

OTHER

lead

University Hospital, Akershus

OTHER

NCT05488899 - Ultra Low Iodine Loaded Spectral CT Angiography (CTA) | Biotech Hunter | Biotech Hunter